[go: up one dir, main page]

SE9904723D0 - New modulators of dopamine neurotransmission II - Google Patents

New modulators of dopamine neurotransmission II

Info

Publication number
SE9904723D0
SE9904723D0 SE9904723A SE9904723A SE9904723D0 SE 9904723 D0 SE9904723 D0 SE 9904723D0 SE 9904723 A SE9904723 A SE 9904723A SE 9904723 A SE9904723 A SE 9904723A SE 9904723 D0 SE9904723 D0 SE 9904723D0
Authority
SE
Sweden
Prior art keywords
alkyl
furane
tetrahydrofurane
thiophene
disclosed
Prior art date
Application number
SE9904723A
Other languages
English (en)
Swedish (sv)
Inventor
Claes Sonesson
Bengt Andersson
Susanna Waters
Nicholas Waters
Joakim Tedroff
Original Assignee
Carlsson A Research Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carlsson A Research Ab filed Critical Carlsson A Research Ab
Priority to SE9904723A priority Critical patent/SE9904723D0/xx
Publication of SE9904723D0 publication Critical patent/SE9904723D0/xx
Priority to EP03027034A priority patent/EP1419773B1/en
Priority to AT03027034T priority patent/ATE397446T1/de
Priority to AU25706/01A priority patent/AU778183B2/en
Priority to PCT/SE2000/002675 priority patent/WO2001046146A1/en
Priority to CA002394606A priority patent/CA2394606C/en
Priority to US10/168,019 priority patent/US6924374B2/en
Priority to HU0203874A priority patent/HUP0203874A3/hu
Priority to MXPA02006317A priority patent/MXPA02006317A/es
Priority to CNB008182582A priority patent/CN1196680C/zh
Priority to DE60039131T priority patent/DE60039131D1/de
Priority to NZ519566A priority patent/NZ519566A/en
Priority to DK03027034T priority patent/DK1419773T3/da
Priority to CZ20022074A priority patent/CZ302907B6/cs
Priority to JP2001547057A priority patent/JP5096654B2/ja
Priority to SK866-2002A priority patent/SK287366B6/sk
Priority to PL362251A priority patent/PL205092B1/pl
Priority to NZ531643A priority patent/NZ531643A/en
Priority to ES03027034T priority patent/ES2307861T3/es
Priority to PT03027034T priority patent/PT1419773E/pt
Priority to IL15035000A priority patent/IL150350A0/xx
Priority to EP00989163A priority patent/EP1240143A1/en
Priority to UA2002076054A priority patent/UA73337C2/uk
Priority to BR0016635-9A priority patent/BR0016635A/pt
Priority to HR20020539A priority patent/HRP20020539B1/xx
Priority to KR1020027008066A priority patent/KR100771287B1/ko
Priority to EEP200200345A priority patent/EE05083B1/xx
Priority to HK03106410.6A priority patent/HK1054228B/zh
Priority to US11/904,013 priority patent/USRE41315E1/en
Priority to RU2002119417/04A priority patent/RU2262504C2/ru
Priority to ZA200204813A priority patent/ZA200204813B/xx
Priority to NO20022879A priority patent/NO323329B1/no
Priority to BG106845A priority patent/BG65698B1/bg
Priority to IL150350A priority patent/IL150350A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Gynecology & Obstetrics (AREA)
  • Addiction (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Liquid Crystal Substances (AREA)
  • Control Of El Displays (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE9904723A 1999-12-22 1999-12-22 New modulators of dopamine neurotransmission II SE9904723D0 (sv)

Priority Applications (34)

Application Number Priority Date Filing Date Title
SE9904723A SE9904723D0 (sv) 1999-12-22 1999-12-22 New modulators of dopamine neurotransmission II
RU2002119417/04A RU2262504C2 (ru) 1999-12-22 2000-12-22 Замещенные 4-(фенил-n-алкил)пиперидины, фармацевтическая композиция на их основе и способы лечения
PL362251A PL205092B1 (pl) 1999-12-22 2000-12-22 Podstawione 4-(fenylo-N-alkilo)piperydyny, zawierające je kompozycje farmaceutyczne i ich zastosowanie
NZ531643A NZ531643A (en) 1999-12-22 2000-12-22 3-Substituted 4-phenyl-piperazine or piperidine derivatives useful as modulators of dopamine neurotransmission
AU25706/01A AU778183B2 (en) 1999-12-22 2000-12-22 New modulators of dopamine neurotransmission
PCT/SE2000/002675 WO2001046146A1 (en) 1999-12-22 2000-12-22 New modulators of dopamine neurotransmission
CA002394606A CA2394606C (en) 1999-12-22 2000-12-22 New modulators of dopamine neurotransmission
US10/168,019 US6924374B2 (en) 1999-12-22 2000-12-22 Modulators of dopamine neurotransmission
HU0203874A HUP0203874A3 (en) 1999-12-22 2000-12-22 Substituted 4-(phenyl-n-alkyl)-piperazine and piperidine derivatives and their use modulators of dopamine neutransmission and pharmaceutical compositions as containing them
MXPA02006317A MXPA02006317A (es) 1999-12-22 2000-12-22 Nuevos moduladores de neurotransmision de dopamina.
CNB008182582A CN1196680C (zh) 1999-12-22 2000-12-22 新的多巴胺神经传递调节剂
DE60039131T DE60039131D1 (de) 1999-12-22 2000-12-22 4-Phenylpiperidin-Derivate als Modulatoren der Dopamin-Neurotransmission
NZ519566A NZ519566A (en) 1999-12-22 2000-12-22 3-Substituted 4-phenyl-piperazine or piperidine derivatives useful as modulators of dopamine neurotransmission
DK03027034T DK1419773T3 (da) 1999-12-22 2000-12-22 4-Phenylpiperidinderivativer som modulatorer af dopaminneurotransmission
CZ20022074A CZ302907B6 (cs) 1999-12-22 2000-12-22 Substituovaná (4-fenyl-N-alkyl)piperidinová sloucenina, její použití a farmaceutická kompozice s jejím obsahem
JP2001547057A JP5096654B2 (ja) 1999-12-22 2000-12-22 ドーパミン神経伝達の新規のモジュレーター
SK866-2002A SK287366B6 (sk) 1999-12-22 2000-12-22 Modulátory neurotransmisie dopamínu
EP03027034A EP1419773B1 (en) 1999-12-22 2000-12-22 4-Phenylpiperidine derivatives as modulators of dopamine neurotransmission
PT03027034T PT1419773E (pt) 1999-12-22 2000-12-22 Derivados de 4-fenilpiperidina como moduladores da neurotransmissão de dopamina
AT03027034T ATE397446T1 (de) 1999-12-22 2000-12-22 4-phenylpiperidin-derivate als modulatoren der dopamin-neurotransmission
ES03027034T ES2307861T3 (es) 1999-12-22 2000-12-22 Derivados de 4-fenilpiperidina como moduladores de la neurotransmision de dopamina.
IL15035000A IL150350A0 (en) 1999-12-22 2000-12-22 New modulators of dopamine neurotransmission
EP00989163A EP1240143A1 (en) 1999-12-22 2000-12-22 New modulators of dopamine neurotransmission
UA2002076054A UA73337C2 (en) 1999-12-22 2000-12-22 Dopamine neurotransmission modulators
BR0016635-9A BR0016635A (pt) 1999-12-22 2000-12-22 Moduladores de neurotransmissão de dopamina
HR20020539A HRP20020539B1 (hr) 1999-12-22 2000-12-22 Novi modulatori transmisije dopamina
KR1020027008066A KR100771287B1 (ko) 1999-12-22 2000-12-22 도파민 신경전달 조절제
EEP200200345A EE05083B1 (et) 1999-12-22 2000-12-22 Dopamiini neurotransmissiooni modulaatorid, nendekasutamine ja neid hendeid sisaldavad farmatseutilised kompositsioonid
HK03106410.6A HK1054228B (zh) 1999-12-22 2000-12-22 新的多巴胺神經傳遞調節劑
US11/904,013 USRE41315E1 (en) 1999-12-22 2000-12-22 Modulators of dopamine neurotransmission
ZA200204813A ZA200204813B (en) 1999-12-22 2002-06-14 New modulators of dopamine neurotransmission.
NO20022879A NO323329B1 (no) 1999-12-22 2002-06-17 Substituerte 4-(fenyl-N-alkyl)-piperidin-forbindelser samt farmasoytiske materialer og anvendelser derav
BG106845A BG65698B1 (bg) 1999-12-22 2002-06-19 Заместени 4-(фенил-n-алкил)-пиперидинови съединения, фармацевтичен състав и използването им в медицината
IL150350A IL150350A (en) 1999-12-22 2002-06-20 New modulators of dopamine neurotransmission

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9904723A SE9904723D0 (sv) 1999-12-22 1999-12-22 New modulators of dopamine neurotransmission II

Publications (1)

Publication Number Publication Date
SE9904723D0 true SE9904723D0 (sv) 1999-12-22

Family

ID=20418252

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9904723A SE9904723D0 (sv) 1999-12-22 1999-12-22 New modulators of dopamine neurotransmission II

Country Status (30)

Country Link
US (2) USRE41315E1 (xx)
EP (2) EP1419773B1 (xx)
JP (1) JP5096654B2 (xx)
KR (1) KR100771287B1 (xx)
CN (1) CN1196680C (xx)
AT (1) ATE397446T1 (xx)
AU (1) AU778183B2 (xx)
BG (1) BG65698B1 (xx)
BR (1) BR0016635A (xx)
CA (1) CA2394606C (xx)
CZ (1) CZ302907B6 (xx)
DE (1) DE60039131D1 (xx)
DK (1) DK1419773T3 (xx)
EE (1) EE05083B1 (xx)
ES (1) ES2307861T3 (xx)
HK (1) HK1054228B (xx)
HR (1) HRP20020539B1 (xx)
HU (1) HUP0203874A3 (xx)
IL (2) IL150350A0 (xx)
MX (1) MXPA02006317A (xx)
NO (1) NO323329B1 (xx)
NZ (2) NZ531643A (xx)
PL (1) PL205092B1 (xx)
PT (1) PT1419773E (xx)
RU (1) RU2262504C2 (xx)
SE (1) SE9904723D0 (xx)
SK (1) SK287366B6 (xx)
UA (1) UA73337C2 (xx)
WO (1) WO2001046146A1 (xx)
ZA (1) ZA200204813B (xx)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9904724D0 (sv) * 1999-12-22 1999-12-22 Carlsson A Research Ab New modulators of dopamine neurotransmission I
USRE46117E1 (en) 1999-12-22 2016-08-23 Teva Pharmaceuticals International Gmbh Modulators of dopamine neurotransmission
SE9904723D0 (sv) 1999-12-22 1999-12-22 Carlsson A Research Ab New modulators of dopamine neurotransmission II
US20070021404A1 (en) * 2003-06-24 2007-01-25 Dan Peters Novel aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
DE10361259A1 (de) * 2003-12-24 2005-07-28 Schwarz Pharma Ag Verwendung von Rotigotine in einem Frühstadium von Morbus Parkinson zur Prävention des weiteren Neuronenverlustes
US7851629B2 (en) 2004-06-08 2010-12-14 Nsab, Filial Af Neurosearch Sweden Ab, Sverige Disubstituted phenylpiperidines as modulators of dopamine and serotonin neurotransmission
SE0401464D0 (sv) * 2004-06-08 2004-06-08 Carlsson A Research Ab New disubstituted phenylpiperidines/piperazines as modulators of dopamine neurotransmission
SE0401465D0 (sv) * 2004-06-08 2004-06-08 Carlsson A Research Ab New substituted piperdines as modulators of dopamine neurotransmission
KR101245075B1 (ko) * 2004-06-08 2013-03-18 엔에스아베 필리알 아프 뉴로서치 스웨덴 아베 스베리게 도파민 신경전달의 모듈레이터로서 신 2기치환된페닐피페리딘/피페라진
EP1768958B1 (en) * 2004-06-08 2009-11-18 NSAB, Filial af NeuroSearch Sweden AB, Sverige New disubstituted phenylpiperidines as modulators of dopamine and serotonin neurotransmission
NZ552410A (en) * 2004-06-08 2010-04-30 Nsab Af Neurosearch Sweden Ab New 4-phenyl-piperidin-4-ol derivatives as modulators of dopamine neurotransmission
KR20070026605A (ko) * 2004-06-18 2007-03-08 뉴로서치 에이/에스 신규한 알킬 치환된 피페라진 유도체 및 모노아민신경전달물질 재흡수 억제제로서의 이의 용도
CN101056854B (zh) 2004-10-13 2013-06-05 Nsab神经研究瑞典公司分公司 合成4-(3-甲磺酰基苯基)-1-n-丙基-哌啶的方法
JP2008515952A (ja) * 2004-10-13 2008-05-15 ニューロサーチ スウェーデン アクチボラゲット ４−（３−スルホニルフェニル）−ピペリジンの合成方法
ITMI20051193A1 (it) * 2005-06-24 2006-12-25 Acraf Uso farmaceutico di una 1-3-clorofenil-3-alchilpiperazina
SE529246C2 (sv) * 2005-10-13 2007-06-12 Neurosearch Sweden Ab Nya disubstituerade fenyl-piperidiner som modulatorer för dopaminneurotransmission
WO2007065655A1 (en) 2005-12-07 2007-06-14 Neurosearch Sweden Ab Disubstituted phenylpiperidines as modulators of cortical catecholaminergic neurotransmission
US9139525B2 (en) * 2007-04-12 2015-09-22 Teva Pharmaceuticals International Gmbh N-oxide and/or di-N-oxide derivatives of dopamine receptor stabilizers/modulators displaying improved cardiovascular side-effects profiles
JP5444535B2 (ja) 2007-06-05 2014-03-19 インテグレイティブ・リサーチ・ラボラトリーズ・スウェーデン・アーベー 皮質カテコールアミン作動性神経伝達の調節物質としての新規な二置換フェニルピロリジン
US20100197760A1 (en) 2007-06-05 2010-08-05 Nsab, Filial Af Neurosearch Sweden Ab, Sverige Disubstituted phenylpyrrolidines as modulators of cortical catecholaminergic neurotransmission
CN102015674B (zh) * 2008-04-29 2014-10-29 Nsab神经研究瑞典公司分公司 多巴胺神经传递调节剂
NZ588209A (en) * 2008-04-29 2012-08-31 Nsab Af Neurosearch Sweden Ab 1-(2,3-dihydro-1,4-benzodioxin-2-yl)-methanamine derivatives for the modulation of dopaminergic function in the central nervous system
WO2009133109A1 (en) * 2008-04-29 2009-11-05 Nsab, Filial Af Neurosearch Sweden Ab, Sverige Modulators of dopamine neurotransmission
WO2011107583A1 (en) 2010-03-04 2011-09-09 Nsab, Filial Af Neurosearch Sweden Ab, Sverige Substituted 4-phenyl-n-alkyl-piperidines for preventing onset or slowing progression of neurodegenerative disorders
MX2013002453A (es) 2010-09-03 2013-08-01 Ivax Int Gmbh Analogos deuterados de pridopidina utiles como estabilizadores dopaminergicos.
MX343620B (es) 2011-09-07 2016-11-11 Teva Pharmaceuticals Int Gmbh Forma polimorfica de clorhidrato de pridopidina.
US9012476B2 (en) 2011-12-08 2015-04-21 IVAX International GmbH Hydrobromide salt of pridopidine
EP2844346B1 (en) 2012-04-04 2020-01-01 Prilenia Neurotherapeutics Ltd. Pharmaceutical compositions for combination therapy
AR105434A1 (es) 2015-07-22 2017-10-04 Teva Pharmaceuticals Int Gmbh Proceso para preparar pridopidina
PT3976581T (pt) * 2019-05-24 2024-02-08 Irl 790 Ab Sais de ácido tartárico de [2-(3-fluoro-5-metanossulfonilfenoxi)etil](propil)amina
CN116554127B (zh) * 2022-01-28 2025-03-21 成都麻沸散医药科技有限公司 哌嗪取代苯酚类衍生物及其用途

Family Cites Families (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2027703A (en) * 1934-06-21 1936-01-14 Ribar Peter Shoe jack
DE1019308B (de) * 1954-07-19 1957-11-14 Hoechst Ag Verfahren zur Herstellung gegen Bilharzia-Infektionen wirksamer 4-Phenyl-piperazine
GB850662A (en) 1956-10-22 1960-10-05 Parke Davis & Co Substituted piperazines and processes for their production
BE662455A (xx) 1964-04-14
GB1060160A (en) 1964-08-05 1967-03-01 Allen & Hanburys Ltd 4-phenylpiperidine derivatives
NL6607959A (xx) * 1965-06-10 1966-12-12
US3539573A (en) 1967-03-22 1970-11-10 Jean Schmutz 11-basic substituted dibenzodiazepines and dibenzothiazepines
CA1061356A (en) * 1975-10-03 1979-08-28 Dieter H. Klaubert 2-cyano-3- or 4-(substituted amino) oxanilic acid derivatives
GB1560271A (en) * 1977-01-14 1980-02-06 Joullie International Sa Therapeutically useful m-trifluoromethylphenylpiperazine derivatives
US4202898A (en) * 1978-06-05 1980-05-13 Synthelabo Method of treating anxiety and depression
FR2459797A2 (fr) * 1978-08-01 1981-01-16 Synthelabo Derives de phenyl-1 piperazine et leur application en therapeutique
US4267328A (en) 1978-08-01 1981-05-12 Synthelabo 1-Phenylpiperazines
US4333942A (en) 1979-08-03 1982-06-08 Byk Gulden Lomberg Chemische Fabrik Gmbh Anti-depressant and analgesic 4-phenoxypiperidines
US4518712A (en) 1980-06-30 1985-05-21 Taiho Pharmaceutical Company Limited Piperazine derivative and analgesic composition containing the same
JPS5714585A (en) * 1980-06-30 1982-01-25 Taiho Yakuhin Kogyo Kk 1-cycloalkylmethylpiperazine derivative
GB2083476B (en) * 1980-09-12 1984-02-08 Wyeth John & Brother Ltd Heterocyclic compounds
FR2501506A1 (fr) 1981-03-11 1982-09-17 Sanofi Sa Compositions pharmaceutiques a action anorexigene contenant des derives de la tetrahydropyridine
JPS5815979A (ja) * 1981-07-11 1983-01-29 Kyowa Hakko Kogyo Co Ltd 新規なピペリジン誘導体およびその製造法
US4415736A (en) 1981-12-28 1983-11-15 E. I. Du Pont De Nemours & Co. Certain tetrahydropyridine intermediates
ATE50987T1 (de) 1982-05-10 1990-03-15 Takeda Chemical Industries Ltd Dihydropyridinderivate, deren herstellung und verwendung.
US4504660A (en) 1982-07-06 1985-03-12 American Home Products Corporation Process for the production of 2,6-diaminobenzonitrile derivatives
ES540226A0 (es) * 1985-02-07 1985-12-01 Inst Investigacion Desarrollo Un nuevo procedimiento de obtencion de derivados del acido quinolincarboxilico
US4892975A (en) 1987-09-28 1990-01-09 President And Fellows Of Harvard College Diethynyl monomers and polymers thereof
HU198454B (en) 1987-12-14 1989-10-30 Richter Gedeon Vegyeszet Process for production of new derivatives of tetrahydrospiridin and medical compositions containing these compounds
FR2639226B1 (fr) 1988-11-18 1993-11-05 Sanofi Utilisation de trifluoromethylphenyltetrahydropyridines pour la preparation de medicaments destines a combattre les troubles anxio-depressifs
AU658134B2 (en) 1989-12-28 1995-04-06 Virginia Commonwealth University Sigma receptor ligands and the use thereof
JP3176063B2 (ja) 1991-04-17 2001-06-11 ファルマシア・アンド・アップジョン・カンパニー 新規中枢神経作用性置換フェニルアザシクロアルカン類
EP0591426A4 (en) * 1991-06-27 1996-08-21 Univ Virginia Commonwealth Sigma receptor ligands and the use thereof
NZ240863A (en) 1991-09-11 1995-04-27 Mcneilab Inc Substituted 4-aryl piperidine and 4-aryl piperazine derivatives, preparation and pharmaceutical compositions thereof
PT533268E (pt) 1991-09-18 2002-02-28 Glaxo Group Ltd Derivados de benzanilida como antagonistas de 5-ht1d
GB9119920D0 (en) * 1991-09-18 1991-10-30 Glaxo Group Ltd Chemical compounds
GB9119932D0 (en) 1991-09-18 1991-10-30 Glaxo Group Ltd Chemical compounds
TW240217B (xx) * 1992-12-30 1995-02-11 Glaxo Group Ltd
GB2276160A (en) * 1993-03-17 1994-09-21 Glaxo Group Ltd Ethanone compounds.
US5502050A (en) * 1993-11-29 1996-03-26 Cornell Research Foundation, Inc. Blocking utilization of tetrahydrobiopterin to block induction of nitric oxide synthesis
EP0659743A1 (en) 1993-12-27 1995-06-28 Hoechst Aktiengesellschaft Piperidine derivatives as inhibitors of platelet aggregation and their preparation
CA2144669A1 (en) * 1994-03-29 1995-09-30 Kozo Akasaka Biphenyl derivatives
US5571822A (en) * 1994-09-30 1996-11-05 The University Of North Carolina At Chapel Hill Antitumor compounds
WO1997003986A1 (fr) 1995-07-19 1997-02-06 Yoshitomi Pharmaceutical Industries, Ltd. Composes fusionnes de triazole
FR2740134B1 (fr) * 1995-10-18 1998-01-09 Pf Medicament Derives d'amines cycliques d'aryl-piperazines, leur preparation et les compositions pharmaceutiques les contenant
US5892041A (en) 1996-08-12 1999-04-06 Neurogen Corporation Fused indolecarboxamides: dopamine receptor subtype specific ligands
DE19637237A1 (de) * 1996-09-13 1998-03-19 Merck Patent Gmbh Piperazin-Derivate
DZ2376A1 (fr) * 1996-12-19 2002-12-28 Smithkline Beecham Plc Dérivés de sulfonamides nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant.
US6232326B1 (en) 1998-07-14 2001-05-15 Jodi A. Nelson Treatment for schizophrenia and other dopamine system dysfunctions
JP2000086603A (ja) 1998-07-15 2000-03-28 Yoshitomi Pharmaceut Ind Ltd 桂皮酸アミド誘導体および３―フェニルプロピオン酸アミド誘導体
IL146403A0 (en) 1999-06-22 2002-07-25 Neurosearch As Novel benzimidazole derivatives and pharmaceutical compositions comprising these compounds
SE9904724D0 (sv) 1999-12-22 1999-12-22 Carlsson A Research Ab New modulators of dopamine neurotransmission I
SE9904723D0 (sv) 1999-12-22 1999-12-22 Carlsson A Research Ab New modulators of dopamine neurotransmission II
US6906120B1 (en) 2000-06-20 2005-06-14 General Electric Poly(arylene ether) adhesive compositions
AU2001280599A1 (en) 2000-07-15 2002-01-30 Smith Kline Beecham Corporation Compounds and methods
US7186715B2 (en) 2001-01-08 2007-03-06 Eli Lilly And Company Piperazine- and piperidine-derivatives as melanocortin receptor agonists
US6663587B2 (en) * 2001-06-22 2003-12-16 Medela Holding Ag Breastshield with multi-pressure and expansible chamber construction, related breastpump and method
US20050004164A1 (en) 2003-04-30 2005-01-06 Caggiano Thomas J. 2-Cyanopropanoic acid amide and ester derivatives and methods of their use
US7160888B2 (en) 2003-08-22 2007-01-09 Warner Lambert Company Llc [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
KR101245075B1 (ko) 2004-06-08 2013-03-18 엔에스아베 필리알 아프 뉴로서치 스웨덴 아베 스베리게 도파민 신경전달의 모듈레이터로서 신 2기치환된페닐피페리딘/피페라진
US7851629B2 (en) 2004-06-08 2010-12-14 Nsab, Filial Af Neurosearch Sweden Ab, Sverige Disubstituted phenylpiperidines as modulators of dopamine and serotonin neurotransmission
EP1768958B1 (en) 2004-06-08 2009-11-18 NSAB, Filial af NeuroSearch Sweden AB, Sverige New disubstituted phenylpiperidines as modulators of dopamine and serotonin neurotransmission
SE0401465D0 (sv) 2004-06-08 2004-06-08 Carlsson A Research Ab New substituted piperdines as modulators of dopamine neurotransmission
SE529246C2 (sv) 2005-10-13 2007-06-12 Neurosearch Sweden Ab Nya disubstituerade fenyl-piperidiner som modulatorer för dopaminneurotransmission
WO2007065655A1 (en) 2005-12-07 2007-06-14 Neurosearch Sweden Ab Disubstituted phenylpiperidines as modulators of cortical catecholaminergic neurotransmission

Also Published As

Publication number Publication date
IL150350A0 (en) 2002-12-01
PL205092B1 (pl) 2010-03-31
EP1240143A1 (en) 2002-09-18
NO20022879L (no) 2002-08-21
US6924374B2 (en) 2005-08-02
NZ519566A (en) 2004-05-28
CN1420870A (zh) 2003-05-28
CZ302907B6 (cs) 2012-01-18
SK287366B6 (sk) 2010-08-09
EE05083B1 (et) 2008-10-15
JP2003518096A (ja) 2003-06-03
CZ20022074A3 (cs) 2002-10-16
US20030004169A1 (en) 2003-01-02
HK1054228B (zh) 2005-09-16
KR100771287B1 (ko) 2007-10-29
CN1196680C (zh) 2005-04-13
WO2001046146A1 (en) 2001-06-28
BR0016635A (pt) 2002-10-15
HK1054228A1 (en) 2003-11-21
DE60039131D1 (de) 2008-07-17
KR20020067565A (ko) 2002-08-22
MXPA02006317A (es) 2004-05-14
RU2262504C2 (ru) 2005-10-20
AU2570601A (en) 2001-07-03
DK1419773T3 (da) 2008-09-22
ZA200204813B (en) 2003-08-27
AU778183B2 (en) 2004-11-18
NZ531643A (en) 2005-03-24
EE200200345A (et) 2003-06-16
EP1419773B1 (en) 2008-06-04
IL150350A (en) 2010-05-31
HRP20020539B1 (hr) 2009-06-30
PT1419773E (pt) 2008-07-01
HUP0203874A2 (hu) 2003-03-28
BG65698B1 (bg) 2009-07-31
CA2394606A1 (en) 2001-06-28
NO323329B1 (no) 2007-03-26
SK8662002A3 (en) 2003-02-04
BG106845A (en) 2003-04-30
RU2002119417A (ru) 2004-01-10
HUP0203874A3 (en) 2005-03-29
HRP20020539A2 (en) 2004-08-31
ATE397446T1 (de) 2008-06-15
EP1419773A2 (en) 2004-05-19
UA73337C2 (en) 2005-07-15
EP1419773A3 (en) 2004-05-26
PL362251A1 (en) 2004-10-18
JP5096654B2 (ja) 2012-12-12
CA2394606C (en) 2009-06-02
USRE41315E1 (en) 2010-05-04
ES2307861T3 (es) 2008-12-01
NO20022879D0 (no) 2002-06-17

Similar Documents

Publication Publication Date Title
SE9904723D0 (sv) New modulators of dopamine neurotransmission II
MXPA02006320A (es) Nuevos moduladores de neurotransmision de dopamina.
NO961655L (no) Visse sammensmeltede pyrrolkarboksanilider; en ny klasse GABA-hjernereseptorligander
HRP20000445B1 (hr) Aril kondenzirani azapoliciklički spojevi
FI911096A0 (fi) N-(4-piperidyl) dihydrobenzofuran)karboxamid- eller n-(4-piperidyl)(dihydro-2h- benzopyran) karboxamidderivat.
MEP22008A (en) Derivatives of n-[heteroaryl(piperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics
SE9702799D0 (sv) New compounds
NO20001402L (no) Substituerte kromanderivater
YU40998A (sh) Derivati supstituisanog 1,2,3,4-tetrahidronaftalina
FI971026A0 (fi) Kinoksaliinidioni-NMDA-reseptoriantagonisteja
NZ333513A (en) 1,4-di-substituted piperidines and medicaments useful as muscarinic antagonists
HRP20070421T3 (hr) Ariloksialkilkarbamatni derivati, njihova priprema i terapeutska primjena
SE9703378D0 (sv) New compounds
ATE166648T1 (de) Benzoxazinderivate, deren herstellung und deren verwendung in therapie
RU2008101776A (ru) Соединения для ингибирования обратного захвата 5-гидрокситриптамина и норэпинефрина или для лечения депрессивных состояний, способы их получения и применения
DE602004021411D1 (de) Peptidomimetische verbindungen, stereoselektives verfahren zu deren herstellung und deren verwendung
NO941830D0 (no) Karboksamid-derivater, deres fremstilling og anvendelse som terapeutika
DK1765779T3 (da) Nye substituerede piperidiner som modulatorer for dopamin-neurotransmission
AR023572A1 (es) Derivados de tetrahidroisoquinolinil-indol para el tratamiento de la depresion y composicion farmaceutica que los comprende